EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Engineering internally his-tagged ESX secretion system fusion antigens for tuberculosis nanoparticle vaccines

Wen-Ling Hsu, Yang Jiao, Wei-Chiao Huang, Kristina N Tran, Brennen T Troyer, Matthew Hvasta, Brian Kuhlman, Andres Obregon-Henao, Jonathan F Lovell

Journal of Biological Chemistry · 2026

DOI: 10.1016/j.jbc.2026.113337 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2026. Verfasst von Wen-Ling Hsu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, University at Buffalo, State University of New York, Buffalo, New York, USA. Hauptthemen laut MEDLINE: Tuberculosis Vaccines, Antigens, Bacterial, Bacterial Proteins, Nanoparticles. Die Arbeit nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIAID NIH HHS, National Institute of Allergy and Infectious Diseases Division of Intramural Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Improved tuberculosis (TB) vaccines are needed to combat the disease, a leading cause of infectious disease death worldwide. The culture filtrate TB antigens ESAT6 and CFP10 form dimeric complexes, serve as immune markers for TB exposure and are vaccine antigen candidates. Here, we report that expressing an ESAT6-CFP10 fusion protein with a conventional glycine-serine (GS) linker sequence significantly enhanced expression yield in E. coli compared to the single antigens. Substituting the GS linker with an internal His-tag generated the ESAT(Int7)CFP fusion, retained elevated expression levels while simultaneously enabled purification with immobilized metal chromatography. The internal His-tag also permitted rapid protein coupling with cobalt-porphyrin (CoPoP) liposomes. Immunization with these constructs elicited antigen-specific antibodies and T cell responses and reduced lung bacterial burden in mice following aerosol TB challenge. Another pair of TB culture filtrate antigens, EsxH and EsxG yielded no soluble protein as individual antigens. However, when linked with an internal His-tag, high soluble expression was observed for EsxH(Int7)EsxG, and this fusion antigen also conferred partial protective immunity in TB challenged mice after vaccination with CoPoP. These findings support the design and manufacturability of multivalent TB vaccine candidates through engineered fusion antigens and nanoparticle delivery platforms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tuberculosis VaccinesAntigens, BacterialBacterial ProteinsNanoparticlesRecombinant Fusion ProteinsHistidineProtein EngineeringAnimalsNanovaccinesMiceMycobacterium tuberculosisProtein Subunit VaccinesFemale

Stichwörter der Autor:innen

fusion proteinlinkerliposomeproteintuberculosisvaccines

Substanzen

Tuberculosis VaccinesAntigens, BacterialNanovaccinesBacterial ProteinsRecombinant Fusion ProteinsHistidineProtein Subunit Vaccines

Autor:innen und Institutionen

  • Department of Biomedical Engineering, University at Buffalo, State University of New York, Buffalo, New York, USA.
  • Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, USA.
  • Department of Biochemistry and Biophysics, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, USA. Electronic address: andres.Obregon@colostate.edu.
  • Department of Biomedical Engineering, University at Buffalo, State University of New York, Buffalo, New York, USA. Electronic address: jflovell@buffalo.edu.

Förderung

  • NIGMS NIH HHS
  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases Division of Intramural Research

Zitieren

APA

Hsu, W. L., Jiao, Y., Huang, W. C., Tran, K. N., Troyer, B. T., Hvasta, M., Kuhlman, B., Obregon-Henao, A., & Lovell, J. F. (2026). Engineering internally his-tagged ESX secretion system fusion antigens for tuberculosis nanoparticle vaccines. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2026.113337

Vancouver

Hsu WL, Jiao Y, Huang WC, Tran KN, Troyer BT, Hvasta M, et al. Engineering internally his-tagged ESX secretion system fusion antigens for tuberculosis nanoparticle vaccines. Journal of Biological Chemistry. 2026. doi:10.1016/j.jbc.2026.113337

BibTeX
@article{Hsu2026,
  author = {Hsu, Wen-Ling and Jiao, Yang and Huang, Wei-Chiao and Tran, Kristina N and Troyer, Brennen T and Hvasta, Matthew and Kuhlman, Brian and Obregon-Henao, Andres and Lovell, Jonathan F},
  title = {Engineering internally his-tagged ESX secretion system fusion antigens for tuberculosis nanoparticle vaccines},
  journal = {Journal of Biological Chemistry},
  year = {2026},
  doi = {10.1016/j.jbc.2026.113337}
}
Kostenlos starten →